fluoroethylcholine (18F) 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
4551 188709-02-6

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • fluoroethylcholine (18F)
  • Molecular weight: 135.19
  • Formula: C6H15FNO
  • CLOGP: -4.11
  • LIPINSKI: 0
  • HAC: 2
  • HDO: 1
  • TPSA: 20.23
  • ALOGS: -2.06
  • ROTB: 4

Drug dosage:

None

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

PropertyDescriptionValueUnitConfidenceSimilarity
azlogd74 LogD at pH 7.4 -3.998 Moderate 0.65
caco2-efflux Caco-2 efflux ratio (BA/AB) 0.461 Moderate 0.65
caco2-intrinsic-papp Caco-2 intrinsic apparent permeability 0.363 10^-6 cm/s Moderate 0.65
dh-clint Dog hepatocyte intrinsic clearance 2.128 uL/min/10^6 cells Moderate 0.65
dppb Dog plasma protein binding (% unbound) 86.350 % Moderate 0.65
fcs-ppb Fetal calf serum protein binding (% unbound) 43.700 % Moderate 0.65
herg hERG pIC50 4.208 pIC50 Moderate 0.65
hh-clint Human hepatocyte intrinsic clearance 3.443 uL/min/10^6 cells Moderate 0.65
hlm-clint Human liver microsomal intrinsic clearance 3.090 uL/min/mg protein Moderate 0.65
hppb Human plasma protein binding (% unbound) 81.330 % Moderate 0.65
kinase-safety-class ACVR2A,ACVR2B,ACVRL1,AKT2,AKT3,AURKA,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK4,CDK5,CDK9,DDR1,DYRK1B,EIF2AK3,EPHB4,ERBB2,FLT3,GRK2,GSK3B,ITK,JAK2,MAP2K6,MAP3K21,MAP3K7,MAPK10,MAPK7,MTOR,NTRK2,PDK1,PDK2,PDK4,PDPK1,PIK3CB,PIK3CG,PIM2,PRKCD,PRKDC,SIK2,SIK3,STK33,SYK,TEK,TGFBR1,TTK,ZAP70 48
kinase-selectivity-class AXL,BRAF,CAMK2D,CDK4,GRK2 5
mdck-mdr1-bcrp-efflux MDCK-MDR1-BCRP efflux ratio 0.462 Moderate 0.65
mdck-mdr1-efflux MDCK-MDR1 efflux ratio 0.089 Moderate 0.65
mh-clint Mouse hepatocyte intrinsic clearance 3.273 Moderate 0.65
mppb Mouse plasma protein binding (% unbound) 92.430 Moderate 0.65
nih-mdck-mdr1-efflux NIH MDCK-MDR1 efflux ratio 0.449 Moderate 0.65
pfas-class PFAS structural alert (1 = True, 0 = False) 0
pppb Pig plasma protein binding (% unbound) 77.780 % Moderate 0.65
rat-kpuu-brain Rat brain Kpuu 0.084 % Moderate 0.65
rh-clint Rat hepatocyte intrinsic clearance 3.589 uL/min/10^6 cells Moderate 0.65
rh-fuinc Rat hepatocyte fraction unbound in incubation 95.420 % Moderate 0.65
rppb Rat plasma protein binding (% unbound) 92.480 % Moderate 0.65
solubility-dd Solubility at pH 7.4 in DMSO 1056.818 uM Moderate 0.65

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC V09IX08 VARIOUS
DIAGNOSTIC RADIOPHARMACEUTICALS
TUMOUR DETECTION
Other diagnostic radiopharmaceuticals for tumour detection

Related Drugs by ATC class:

V09IX Other diagnostic radiopharmaceuticals for tumour detection 10 drugs

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
CHEMBL3707264 ChEMBL_ID
C2348690 UMLSCUI
10103319 PUBCHEM_CID
407582-17-6 SECONDARY_CAS_RN
290587400Z UNII
361GS6D83C UNII

Pharmaceutical products:

None